Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05167734 · ClinicalTrials.gov registry record · Phase 2
Practical Anemia Bundle for SusTained Blood Recovery
A Phase 2 study of Critical Illness and Anemia, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT05167734: Completed Phase 2 study of Critical Illness and Anemia, sponsored by Mayo Clinic.
NCT05167734 is a Phase 2 study of Critical Illness and Anemia that has completed, run by Mayo Clinic. The registered enrollment target is 100 participants, below the 3,137-participant average among 91 other Critical Illness trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05167734, a Phase 2 study of Critical Illness and Anemia, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test a multi-faceted anemia treatment plan to reduce the severity of anemia and to promote hemoglobin and functional recovery in adults who have been in the intensive care unit (ICU).
Primary Outcome
Hemoglobin is a protein that cares oxygen through the body
Conditions Studied
Interventions
- DRUG Iron Dextran
- DRUG Erythropoietin (EPO)
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-11-30 |
| Est. Completion | 2024-11-26 |
| Phase | Phase 2 |
What the finished NCT05167734 record still lists
NCT05167734 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 3,137-participant average among 91 other Critical Illness trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Critical Illness appearing as the primary indexed condition, and to 2 interventions - of which Iron Dextran is the first listed.
NCT05167734 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05167734 about?
NCT05167734 is a clinical study titled "Practical Anemia Bundle for SusTained Blood Recovery". The purpose of this study is to test a multi-faceted anemia treatment plan to reduce the severity of anemia and to promote hemoglobin and functional recovery in adults who have been in the intensive care unit (ICU).
What is the current status of trial NCT05167734?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2021-11-30. Estimated completion is 2024-11-26.
What conditions does trial NCT05167734 study?
This clinical trial studies the following conditions: Critical Illness, Anemia.
What interventions are being tested in trial NCT05167734?
The interventions under investigation include: Iron Dextran (DRUG), Erythropoietin (EPO) (DRUG).
Who is sponsoring clinical trial NCT05167734?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05167734 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Critical Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05167734's enrollment target sits among peer trials
100 63rd of 91 higher than 24 of 91 other Critical Illness trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Critical Illness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The "What Is Important to Us" Communication Intervention Pilot Clinical Trial
RECRUITING · Phase 2
-
Azithromycin for Critical Asthma - Pediatrics
RECRUITING · Phase 2
-
Hypovitaminosis D in Neurocritical Patients
COMPLETED · Phase 2
-
Inulin for Infections in the Intensive Care Unit
COMPLETED · Phase 2
-
Preoperative Fasting vs. Not Fasting in Critically Ill Patients
RECRUITING · NA
-
Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI